시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
바이오의약품 가공 장비와 소모품 시장 규모, 점유율, 예측, 제품 유형별, 용도별, 동향 분석 - 세계 예측(2031년)
Biopharmaceutical Processing Equipment and Consumables Market Size, Share, Forecast, & Trends Analysis by Product Type, Application - Global Forecast to 2031
상품코드 : 1535299
리서치사 : Meticulous Research
발행일 : 2024년 08월
페이지 정보 : 영문 294 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,175 ￦ 6,059,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄는 1회만 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 5,875 ￦ 8,526,000
PDF (Multi User License) help
PDF 보고서를 동일 사업장에서 5명까지 이용할 수 있는 라이선스입니다. 인쇄는 5회 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 7,875 ￦ 11,429,000
PDF (Global Site License) help
PDF 보고서를 동일 기업 및 자회사의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.

한글목차

바이오의약품 가공 장비와 소모품 시장 : 제품 유형별(여과, 크로마토그래피, 바이오리액터, 세포배양액, 쉐이커, 서비스), 용도별(백신, mAb, 연구개발) - 시장 규모, 점유율, 예측, 동향 분석(-2031년)

세계의 바이오의약품 가공 장비와 소모품 시장은 2023년에 363억 8,000만 달러로 평가되었습니다. 이 시장은 2024년 추정 402억 2,000만 달러에서 2031년에는 757억 2,000만 달러에 달할 것으로 예측되며, 2024-2031년의 예측 기간 중 CAGR은 9.5%입니다.

광범위한 2차 조사와 1차 조사, 시장 시나리오의 면밀한 분석을 통해 주요 업계 촉진요인·억제요인·과제·기회를 식별하고 있습니다. 이 시장의 성장은 바이오의약품 시장의 성장, 바이오의약품 플랜트의 능력 확장, 일회용 바이오프로세싱 장비의 채택 증가에 의해 촉진됩니다. 또한 신흥 국가, 바이오프로세싱 4.0으로의 이동, 맞춤형 의약품의 채택 증가는 이 시장의 이해관계자에게 성장 기회를 제공할 것으로 기대되고 있습니다.

본 리포트에는 시장 참여 기업이 과거 3년간(2021-2024년) 채택한 주요 전략적 발전의 광범위한 평가에 기반한 경쟁 구도가 포함되어 있습니다. 세계의 바이오의약품 가공 장비와 소모품 시장 보고서에 프로파일링된 주요 기업에는 3M Company(미국), Bio-Rad Laboratories, Inc(미국), Thermo Fisher Scientific Inc(미국), Danaher Corporation(미국), Agilent Technologies, Inc(미국), Repligen Corporation(미국), Sartorius AG(독일), Merck KGaA(독일), Eppendorf AG(독일), Solaris Biotechnology Srl(이탈리아)가 있습니다.

목차

제1장 서론

제2장 조사 방법

제3장 개요

제4장 시장 인사이트

제5장 세계의 바이오의약품 가공 장비와 소모품 시장 : 제품 유형별

제6장 바이오의약품 가공 장비와 소모품 시장 : 용도별

제7장 바이오의약품 가공 장비와 소모품 시장 : 최종사용자별

제8장 바이오의약품 가공 장비와 소모품 시장 : 지역별

제9장 경쟁 구도

제10장 기업 개요

제11장 부록

KSA
영문 목차

영문목차

Biopharmaceutical Processing Equipment and Consumables Market Size, Share, Forecast, & Trends Analysis by Product Type (Filtration, Chromatography, Bioreactors, Cell Culture Media, Shakers, Services), Application (Vaccine, mAb, R&D)-Forecast to 2031

The global biopharmaceutical processing equipment and consumables market was valued at $36.38 billion in 2023. This market is expected to reach $75.72 billion by 2031 from an estimated $40.22 billion in 2024, at a CAGR of 9.5% during the forecast period of 2024-2031.

After extensive secondary and primary research and in-depth analysis of the market scenario, the report identifies the key industry drivers, restraints, challenges, and opportunities. This market's growth is driven by the growing biopharmaceuticals market, biopharmaceutical plant capacity expansions, and the rising adoption of single-use bioprocessing equipment. Furthermore, emerging economies, the shift toward Bioprocessing 4.0, and the rising adoption of personalized medicines are expected to generate growth opportunities for the stakeholders in this market.

The report includes a competitive landscape based on an extensive assessment of the key strategic developments that led market participants to adopt over the past three years (2021-2024). The key players profiled in the global biopharmaceutical processing equipment and consumables market report are 3M Company (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), Danaher Corporation (U.S.), Agilent Technologies, Inc (U.S.), Repligen Corporation (U.S.), Sartorius AG (Germany), Merck KGaA (Germany), Eppendorf AG (Germany), and Solaris Biotechnology Srl (Italy).

Based on product type, the filtration systems segment is estimated to account for the largest share of the market in 2024, at 22.3%. The filtration systems are used repeatedly at every stage of the bioprocessing process, and their technological developments and repeatability are the main reasons contributing to the highest share. The development of single-use filtration systems and enhanced filtration titers are the primary areas of technological innovation in filtration.

Based on application, the market is segmented into commercial bioproduction and research bioproduction. In 2024, The commercial bioproduction segment is estimated to account for the larger share of 77.5% of the global biopharmaceutical processing equipment and consumables market to meet the growing demand for biopharmaceuticals. Biopharmaceutical companies are expanding their production capacities, developing new facilities, and moving to emerging biopharmaceutical hubs like India and Singapore, further accelerating the demand for biopharmaceutical processing equipment.

Based on end user, the global biopharmaceutical processing equipment and consumables market is categorized into pharmaceutical & biopharmaceutical companies, contract development and manufacturing organizations (CDMOs), and academic & research institutes. The biopharmaceutical processing equipment and consumables market is expected to be dominated by the pharmaceutical & biopharmaceutical firms sector by 2024. The growing demand for biopharmaceutical goods has led to a notable surge in growth for pharmaceutical and biopharmaceutical companies in recent times, with the latter holding the biggest part of the market. The largest share of the market is also supported by initiatives taken by governments in various nations, which include funding and grants to pharmaceutical and biopharmaceutical companies for the production and R&D of biopharmaceuticals and an increase in facility expansion by major players.

An in-depth analysis of the geographical scenario of the biopharmaceutical processing equipment and consumables market provides detailed qualitative and quantitative insights into five major geographies (North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa) and covers major countries in each region.

In 2024, Europe is estimated to command the largest share of the 33.5% biopharmaceutical processing equipment and consumables market, followed by North America, Asia-Pacific, Latin America, and Middle East & Africa. The availability of top producers of consumables and equipment for biopharmaceutical processing, rising drug sales, encouragement from regulatory and governmental bodies to use biopharmaceuticals for a range of medical conditions, and a number of businesses growing both their production and operational capabilities.

Scope of the Report:

Global Biopharmaceutical Processing Equipment and Consumables Market, by Product Type

Note: Other equipment and consumables include membrane adsorbers, cell disruption reagents, pipettes, syringes, vials, closures, tubing, connectors, and sensors.

Global Biopharmaceutical Processing Equipment and Consumables Market, by Application

Global Biopharmaceutical Processing Equipment and Consumables Market, by End User

Global Biopharmaceutical Processing Equipment and Consumables Market, by Geography

TABLE OF CONTENTS

1. Introduction

2. Research Methodology

3. Executive Summary

4. Market Insights

5. Global Biopharmaceutical Processing Equipment and Consumables Market-by Product Type

6. Biopharmaceutical Processing Equipment and Consumables Market-by Application

7. Biopharmaceutical Processing Equipment & Consumables Market-by End User

8. Biopharmaceutical Processing Equipment and Consumables Market-by Geography

9. Competitive Landscape

10. Company Profiles

11. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기